Clinical Trials Browser

Active not recruiting × Triple Negative Breast Neoplasms × sacituzumab govitecan × Clear all

NCT04454437 2026-02-02

Study of Sacituzumab Govitecan in Chinese Patients With Metastatic Triple-negative Breast Cancer Who Received at Least Two Prior Treatments

Phase 2 Active not recruiting

Triple Negative Breast Neoplasms

NCT04595565 2025-11-25

SASCIA

Phase 3 Active not recruiting

Triple Negative Breast Neoplasms

NCT05382299 2025-09-05

ASCENT-03

Phase 3 Active not recruiting

Triple Negative Breast Neoplasms

NCT05101096 2025-03-25

ASCENT-J02

Phase 1/2 Active not recruiting

Triple Negative Breast Neoplasms